COMMUNIQUÉS West-GlobeNewswire

RavenQuest Completes Final Tranche of Non-Brokered Private Placement
29/03/2019
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS VANCOUVER, British Columbia, March [...]
Total number of shares and voting rights in Zealand Pharma at March 31, 2019
29/03/2019
Company announcement – No. 09 / 2019 Total number of shares and voting rights in Zealand Pharma at March 31, 2019 Copenhagen, March 29, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL), a Copenhagen-based [...]
Athenex Announces Appointment of Jordan S. Kanfer to Board of Directors
29/03/2019
Jordan Kanfer to replace SongYi Zhang, J.D., who is stepping down BUFFALO, N.Y., March 29, 2019 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, [...]
Xeris Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
29/03/2019
CHICAGO, March 29, 2019 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable [...]
Autolus Therapeutics Announces Conference Call to Discuss AUTO1 ALLCAR19 Data Presentation at the AACR Annual Meeting 2019
29/03/2019
Conference Call and Webcast to Be Held Tuesday, April 2, 2019 at 8:00 am ET / 1:00 pm BST LONDON, March 29, 2019 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company [...]
TG Therapeutics to Present Interim Data from the UNITY-NHL Phase 2b Trial Evaluating Umbralisib Monotherapy in Patients with Marginal Zone Lymphoma at the Upcoming 2019 AACR Annual Meeting
29/03/2019
Abstract and full presentation will be publicly available Monday April 1, 2019 at 8:30am ET Company to host conference call on Monday, April 1, 2019 at 12:00pm (noon) ET, with Dr. Nathan Fowler of MD Anderson Cancer [...]
LipoMedix to Present New Clinical Data on Promitil® at American Association for Cancer Research (AACR) Annual Meeting 2019
29/03/2019
Givat Ram High-Tech Village, Jerusalem, March 29, 2019 (GLOBE NEWSWIRE) -- Lipomedix, a clinical-stage, oncology-focused pharmaceutical company, involved in the development of innovative, safe and effective cancer [...]
ERYTECH Announces Filing of 2018 “Document de Référence” and 2018 Annual Report on Form 20-F
29/03/2019
LYON, France, March 29, 2019 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris: ERYP – Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative by encapsulating therapeutic drug substances inside [...]
ERYTECH annonce le dépôt de son Document de Référence 2018 et de son Form 20-F 2018
29/03/2019
LYON, France, 29 mars 2019 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris : ERYP – Nasdaq : ERYP), société biopharmaceutique de stade clinique qui développe des thérapies innovantes en encapsulant des médicaments [...]
Constitution of the Board of Directors in Genmab A/S and Grant of Restricted Stock Units and Warrants to Employees in Genmab
29/03/2019
Company Announcement Copenhagen, Denmark; March 29, 2019 – Following Genmab A/S’ (Nasdaq Copenhagen: GEN) Annual General Meeting held on March 29, 2019, the Company’s Board of Directors met to constitute itself. Mr. [...]
Award of Share Options
29/03/2019
Summit Therapeutics plc (‘Summit’ or the ‘Company’) Award of Share Options Oxford, UK, and Cambridge, MA, US, 29 March 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), a leader in new mechanism antibiotic [...]
Award of Share Options
29/03/2019
Summit Therapeutics plc (‘Summit’ or the ‘Company’) Award of Share Options Oxford, UK, and Cambridge, MA, US, 29 March 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), a leader in new mechanism antibiotic [...]
ReWalk Robotics Completes One-for-Twenty-Five Reverse Share Split
29/03/2019
YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., March 29, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ ReWalk ” or the “ Company ”) reported today that it has completed the reverse share split of ReWalk [...]
Kiadis Pharma Announces Results of Extraordinary General Meeting of Shareholders
29/03/2019
Kiadis Pharma Announces Results of Extraordinary General Meeting of Shareholders Amsterdam, The Netherlands, March 29, 2019 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS [...]
Genfit: GENFIT Announces Closing of Global Offering and Full Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares
29/03/2019
FOR IMMEDIATE RELEASE GENFIT Announces Closing of Global Offering and Full Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares Global Offering Gross Proceeds Totaling $155.4 Million Lille [...]
Genfit : GENFIT annonce le règlement-livraison de l’Offre Globale
29/03/2019
CE COMMUNIQUÉ N’EST PAS DESTINÉ A ÊTRE PUBLIÉ, DISTRIBUÉ OU DIFFUSÉ, DIRECTEMENT OU INDIRECTEMENT, AUX ÉTATS-UNIS D’AMÉRIQUE NI À DES RESSORTISSANTS AMÉRICAINS (« U.S. PERSONS »), POUR LEUR BÉNÉFICE OU POUR LEUR COMPTE [...]
Vigil Health Solutions Establishes Automatic Share Purchase Plan
29/03/2019
VICTORIA, British Columbia, March 29, 2019 (GLOBE NEWSWIRE) -- Vigil Health Solutions Inc. (“ V i g i l ” or the “ Company ”) (TSX-VEN: VGL) today announced that, in connection with its previously announced normal [...]
Increase in the number of shares and votes in Oasmia Pharmaceutical AB (publ)
29/03/2019
The number of shares and votes in Oasmia Pharmaceutical AB (publ) has increased as a result of the directed new share issue carried out in March 2019. Through the directed share issue the number of outstanding shares [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 28 février 2019
29/03/2019
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 28 février 2019 En application de l'article L. 233-8 II du code de commerce et de l'article 222-12-5 du règlement général de l'AMF, [...]

Pages